Camurus AB

Description

Develops innovative, long-acting treatments for severe and chronic diseases; used by patients and healthcare systems addressing unmet medical needs in CNS, rare diseases, endocrinology, oncology and supportive care.

Related

• TareBioDevelops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment for…
• Crinetics Pharmaceuticals, Inc.Crinetics Pharmaceuticals develops endocrine-focused medicines, advancing programs and partnerships intended to improve treatment options…
• Hansa Biopharma ABDevelops immunomodulating therapies using antibody-cleaving enzyme technology for patients with rare IgG-driven immunologic conditions, and…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
• Neumora TherapeuticsDevelops treatments for brain diseases, advancing CNS-targeted medicines and precision approaches to understand disease biology and…
• Herantis Pharma OyjHerantis Pharma develops therapies for neurodegenerative diseases.
• Novo Nordisk A/SBuilds medicines and treatments for people with diabetes and obesity; used by patients, healthcare professionals, and researchers for…
• TheratechnicaTheratechnica develops medical technology solutions, including VR, AR, medical apps, and AI tools.
• Sangamo Therapeutics ($SGMO)Develops genomic medicines using zinc finger technology for patients with severe diseases where current treatments may offer mainly symptom…
• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
• Archangel HealthProvide infrastructure software that powers medical artificial intelligence systems, helping healthcare teams operate models for clinical…